July 21, 2017 2:08 PM ET

Pharmaceuticals

Company Overview of Galderma Laboratories, L.P.

Company Overview

Galderma Laboratories, L.P. researches and develops, produces, markets, and sells medical solutions to skin health and dermatological needs of patients at various ages and stages of life. It offers a portfolio of prescription, self-medication, and aesthetic and corrective medical solutions that include cleansers and moisturizers, acne products, and topical anesthetic products. The company’s products are used to treats a range of dermatological conditions, including acne, rosacea, onychomycosis, psoriasis and steroid-responsive dermatoses, skin pigmentary disorders, skin cancer, and medical solutions for skin senescence. Its products are sold in the United States, Canada, and internationally....

14501 North Freeway

Fort Worth, TX 76177

United States

Founded in 1961

Phone:

817-961-5000

Fax:

817-961-0041

Key Executives for Galderma Laboratories, L.P.

Chief Executive Officer
President and General Manager
President of North American Operations
Senior Vice President of Medical and Regulatory Affairs
Age: 55
Vice President of US Trade and Self-Medication Business Unit
Compensation as of Fiscal Year 2017.

Galderma Laboratories, L.P. Key Developments

Galderma Presents Results from Phase 4 Clinical Studies of Restylane® Refyne and Restylane® Defyne

Galderma announced the results from two Phase 4 clinical studies of its most recent additions to the Restylane® family of products in the U.S., Restylane® Refyne and Restylane® Defyne. Results from these studies will be presented during the Galderma Symposium at the 15th Aesthetic & Anti-aging Medicine Annual World Congress (AMWC) taking place from April 6-8 in Monaco. The Natural Expression study found that naturalness in facial expressions was at least maintained in 95% (60/63) of subjects (primary objective).Additionally, results from the Dynamic Strain study found that 83% (25/30) of subjects had enhanced attractiveness, looked younger and at least maintained naturalness, post Restylane® Refyne and Restylane® Defyne injections. Restylane® Refyne and Restylane® Defyne were recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of nasolabial folds (NLF) or "laugh lines," in patients over the age of 21. Restylane® Refyne was approved for the treatment of moderate to severe facial wrinkles and folds, such as NLF, and Restylane® Defyne for the treatment of moderate to severe, deep facial wrinkles and folds, such as NLF. These scientifically-advanced gels are manufactured with XpresHAn Technology™† (pronounced ex-'spre-sh?n), creating gels that offer a range of flexibility and support for varied patient needs.

Galderma Laboratories Expands Skincare Portfolio to Include Seven New Facial Care Products in 2017

Galderma Laboratories, L.P. announced the launch of seven new facial skincare products to the Cetaphil portfolio. The Brand will now offer a wider range of specialized solutions that address key skin concerns, including hydration, effective makeup removal and skin prone to redness. The new collection includes: Cetaphil® Daily Hydrating Lotion – lightweight, oil-free moisturizer formulated with Hyaluronic Acid provides instant hydration to skin and locks in moisture to protect skin from dryness. Cetaphil® Rich Hydrating Night Cream – rich, nourishing night cream – formulated with nourishing Hyaluronic Acid, Pro-Vitamin Complex and Olive Extract – helps retain skin's natural moisture, protecting it from dryness throughout the night while gently soothing skin. Cetaphil® Gentle Makeup Removing Wipes – convenient and ultra-gentle wipes – formulated with Aloe Vera, Green Tea and Chamomile – effectively lift even waterproof makeup from all over your face for a soothing cleansing experience. Cetaphil® Gentle Makeup Remover – oil-free, bi-phase liquid – formulated with Aloe Vera, Ginseng and Green Tea – gently and effectively dissolves even waterproof makeup, leaving skin feeling smooth, clean and refreshed. Cetaphil® Foaming Face Wash – extra gentle cleanser washes away dirt, impurities and makeup that can clog pores and irritate sensitive skin. Cetaphil® Redness Relieving Daily Facial Moisturizer – neutral tinted moisturizer with SPF 20 – specially formulated for skin prone to redness – neutralizes the appearance of redness, evens skin tone and hydrates the natural protective skin barrier, leaving it soothed and balanced. Cetaphil® Redness Relieving Night Moisturizer – rich hydrating moisturizer is specifically formulated for skin prone to redness and provides continuous moisture to reduce appearance of redness due to dryness overnight.

Galderma Announces Skincare Collaboration with Colorescience

Galderma announced a collaboration with Colorescience, the leading dermatologist-recommended skin health cosmetics line. This collaboration expands skincare solutions to individuals who seek innovative daily skincare products that can be used in conjunction with traditional facial injectable aesthetic treatments. Galderma and Colorescience will provide first-in-class product offerings to aesthetic healthcare professionals and women looking for innovative skincare solutions. Research shows that there are currently 2 million U.S. women who regularly participate in the aesthetic injectables market, while approximately 17 million are considering aesthetic injectable treatment.1 Additionally, approximately 34 million U.S. women purchase skincare products at their doctor's office annually.1 This collaboration provides a significant opportunity to leverage the overlapping markets, providing exposure to the population interested in both. It will increase access to aesthetic facial injectables and protective makeup products to more cosmetic and dermatology practices. The marketing collaboration will include certain brands of Galderma's aesthetic facial injectables and some of Colorescience's most popular cosmetic and skincare products in the U.S. market. The Galderma and Colorescience collaboration will leverage both companies' consumer expertise and continued commitment to innovative skincare solutions. Through this new collaboration, the two companies will seek opportunities to leverage their combined consumer expertise and market growth strategies to benefit both healthcare professionals and consumers.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Galderma Laboratories, L.P., please visit www.galdermausa.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.